bpc-157 / tb500 pen + TB-500 (Blend) - 5/5mg Skin Glow (GHK-Cu/TB-500/BPC-157) Next-Gen Dual-Chamber

The loading phase (Weeks 14) uses twice-weekly dosing to establish tissue saturation, followed by a maintenance phase (Weeks 512) at once weekly [1]

nonetheless, the mortality rate of severe patients remains as high as 4050% [4], which makes the treatment of invasive fungal infections a major clinical challenge

An explanation for this could be the slow regeneration of the olfactory neurons, leading to the coexistence of mature and newly formed neurons

One regulatory note worth holding alongside his framing: the FDA placed several of the peptides he discusses (including BPC-157, CJC-1295, and Ipamorelin) onto a Category 2 list in 2023, citing a lack of safety data rather than reported harms

In the study by Neelakantan et al